ESMO Events App
Create your own personalised agenda and browse the scientific programme by day, topic, cancer type and track with the ESMO events app.
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Browse the high quality scientific and educational content from the ESMO Congress 2024
Updated data from two studies report significant improvements in recurrence-free survival and distant-metastasis free survival with pembrolizumab or nivolumab
Efficacy and safety of telisotuzumab adizutecan was investigated in patients with EGFR wild type non-squamous disease
Evidence from well-designed clinical trials is key to promote greater acceptance and access to palliative care
The combination therapy with the CDK 4/6 inhibitor improved overall response rate compared to standard treatment
Strategies to target MTAP deletion, KRAS G12D and ESR1 mutations, and CDK4 and CDK2 further expand the landscape of precision oncology
Create your own personalised agenda and browse the scientific programme by day, topic, cancer type and track with the ESMO events app.
Fira Barcelona Gran Via
Av. Joan Carles I, 64
08908 L’hospitalet de Llobregat
Barcelona, Spain
ESMO 2024 disseminated the latest cutting-edge data, provided high quality education and excellent networking opportunities for oncologists and other stakeholders from all around the world.
The innovative, LIVE Plus Congress format offered participants the option to attend in person, in Barcelona or online, through the Virtual Congress Platform, from 13-17 September 2024.
-An outstanding scientific & educational event for the oncology community
Andrés Cervantes
-A place where international perspectives convene to design the next generation of studies and trials
Rebecca Dent
-An event where multidisciplinarity meets scientific excellence for better patient outcomes
Karin Jordan
DISCLAIMER
ESMO is a scientific and professional, non-political and non-religious organisation. As such, and in light of the tragic events unfolding in so many parts of the world, ESMO will not accept responsibility for any comments or remarks made during the ESMO Congress 2024 by session chairs, invited speakers, presenters, members or any other contributor, formally or informally, which might cause offence or be perceived as being biased.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.